FABRICATION OF BIODEGRADABLE IMPLANTABLE DEVICES FOR SUSTAINED LOCALIZED DRUG RELEASE

0
76
You can download this material now from our portal

FABRICATION OF BIODEGRADABLE IMPLANTABLE DEVICES FOR SUSTAINED LOCALIZED DRUG RELEASE

Abstract:
The development of biodegradable implantable devices for sustained localized drug release has emerged as a promising strategy in the field of biomedical engineering. These devices offer a unique solution for delivering therapeutic agents directly to targeted tissues, minimizing systemic side effects and improving patient compliance. This abstract provides an overview of the fabrication techniques and key considerations involved in the design and development of such devices.

The fabrication process of biodegradable implantable devices begins with the selection of suitable biocompatible materials with controlled degradation rates. Biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA), have gained significant attention due to their excellent biocompatibility and tunable degradation properties. The choice of drug and its incorporation within the device also plays a crucial role in achieving the desired therapeutic effect. Furthermore, the device design should allow for controlled release kinetics, ensuring sustained drug release over an extended period.

Various fabrication techniques, including microfabrication, 3D printing, and electrospinning, have been employed to produce biodegradable implantable devices. Microfabrication techniques enable precise control over device geometry and drug loading, while 3D printing allows for the creation of complex structures with customizable drug release profiles. Electrospinning offers a versatile approach to fabricate nanofibrous scaffolds that can be easily integrated into implantable devices.

To achieve sustained localized drug release, biodegradable implantable devices can be designed as reservoir-based or matrix-based systems. Reservoir-based devices involve encapsulating drugs within a reservoir, which is surrounded by a biodegradable polymer membrane. As the polymer degrades, the drug is gradually released. In matrix-based systems, the drug is dispersed within the polymer matrix, and its release occurs as the polymer degrades and forms porous structures.

The successful fabrication of biodegradable implantable devices requires careful consideration of factors such as material selection, drug loading, device design, and fabrication technique. Moreover, the biocompatibility, mechanical properties, and degradation kinetics of the device should be thoroughly characterized to ensure its safety and efficacy.

In conclusion, the development of biodegradable implantable devices for sustained localized drug release holds great promise for improving the treatment of various diseases. By utilizing suitable fabrication techniques and materials, researchers can design devices that offer controlled and prolonged drug release, leading to enhanced therapeutic outcomes and reduced side effects. Further research is warranted to optimize these devices and translate them into clinical applications for the benefit of patients worldwide.

FABRICATION OF BIODEGRADABLE IMPLANTABLE DEVICES FOR SUSTAINED LOCALIZED DRUG RELEASE, GET MORE MATERIALS SCIENCE AND ENGINEERING

Leave a Reply